Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Total Non-Current Liabilities (2018 - 2025)

Cosmos Health (COSM) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $44.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities rose 57.69% year-over-year to $44.7 million, compared with a TTM value of $44.7 million through Sep 2025, up 57.69%, and an annual FY2024 reading of $29.4 million, up 4.23% over the prior year.
  • Total Non-Current Liabilities was $44.7 million for Q3 2025 at Cosmos Health, up from $35.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $45.0 million in Q4 2021 and bottomed at $23.6 million in Q1 2023.
  • Average Total Non-Current Liabilities over 5 years is $34.1 million, with a median of $29.4 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities tumbled 39.61% in 2023, then surged 57.69% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $45.0 million in 2021, then plummeted by 37.06% to $28.3 million in 2022, then dropped by 0.42% to $28.2 million in 2023, then increased by 4.23% to $29.4 million in 2024, then soared by 51.94% to $44.7 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for COSM at $44.7 million in Q3 2025, $35.2 million in Q2 2025, and $29.1 million in Q1 2025.